4//SEC Filing
Garipalli Vivek 4
Accession 0001801170-25-000027
CIK 0001801170other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:34 PM ET
Size
19.6 KB
Accession
0001801170-25-000027
Insider Transaction Report
Form 4
Garipalli Vivek
Director10% Owner
Transactions
- Exercise/Conversion
Class A Common Stock
2025-01-07+1,670,965→ 3,080,232 total - Exercise/Conversion
Restricted Stock Unit
2025-01-07−3,342,698→ 3,342,699 total→ Class B Common Stock (3,342,698 underlying) - Tax Payment
Class A Common Stock
2025-01-07$3.60/sh−1,670,965$6,015,474→ 1,409,267 total - Exercise/Conversion
Class B Common Stock
2025-01-07+3,342,698→ 8,575,308 total→ Class A Common Stock (3,342,698 underlying) - Exercise/Conversion
Class B Common Stock
2025-01-07−1,670,965→ 6,904,343 total→ Class A Common Stock (1,670,965 underlying)
Holdings
- 75,694,143(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (75,694,143 underlying) - 2,062,265(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (2,062,265 underlying) - 5,645,934(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (5,645,934 underlying) - 182,201(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (182,201 underlying)
Footnotes (4)
- [F1]The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.
- [F2]On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.
- [F4]The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839260
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:34 PM ET
- Size
- 19.6 KB